MORRIS PLAINS, N.J., May 3, 2011 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, is scheduled to present at the Bank of America Merrill Lynch 2011 Health Care Conference at 10:40 a.m. on Tuesday, May 10, 2011, at the Encore at Wynn in Las Vegas, NV. The presentation, which can be downloaded simultaneously at www.immunomedics.com/1aboutus/present.pdf, will provide a corporate overview.
